Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study
- PMID: 37629346
- PMCID: PMC10455112
- DOI: 10.3390/jcm12165304
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study
Abstract
The coronavirus disease 19 (COVID-19) emergency led to rearrangements of healthcare systems with a significant impact on those internal medicine departments that had not been converted to COVID-19 wards. A reduced number of departments, indeed, had to cope with the same number of patients along with a lack of management of patients' chronic diseases. We conducted a retrospective study aimed at examiningthe consequences of the COVID-19 pandemic on internal medicine departments that were not directly managing COVID-19 patients. Data from 619 patients were collected: 247 subjects hospitalized in 2019 (pre-COVID-19 era), 178 in 2020 (COVID-19 outbreak era) and 194 in 2021 (COVID-19 ongoing era). We found that in 2020 in-hospital mortality was significantly higher than in 2019 (17.4% vs. 5.3%, p = 0.009) as well as length of in-hospital stay (LOS) (12.7 ± 6.8 vs. 11 ± 6.2, p = 0.04). Finally, we performed a logistic regression analysis of the major determinants of mortality in the entire study population, which highlighted an association between mortality, being bedridden (β = 1.4, p = 0.004), respiratory failure (β = 1.5, p = 0.001), glomerular filtration rate (β = -0.16, p = 0.03) and hospitalization in the COVID-19 outbreak era (β = 1.6, p = 0.005). Our study highlights how the COVID-19 epidemic may have caused an increase in mortality and LOS even in patients not directly suffering from this infection.
Keywords: COVID-19; in-hospital mortality; in-hospital outcomes; internal medicine departments; length of in-hospital stay; sepsis.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- WHO Coronavirus (COVID-19) Dashboard. [(accessed on 7 June 2022)]. Available online: https://covid19.who.int.
-
- Reed C., Lim T., Montgomery J.M., Klena J.D., Hall A.J., Fry A.M., Cannon D.L., Chiang C.-F., Gibbons A., Krapiunaya I., et al. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, 23 March–12 May 2020. JAMA Intern. Med. 2020;180:1576–1586. doi: 10.1001/jamainternmed.2020.4130. - DOI - PMC - PubMed
-
- Metzger C., Leroy T., Bochnakian A., Jeulin H., Gegout-Petit A., Legrand K., Schvoerer E., Guillemin F. Seroprevalence and SARS-CoV-2 Invasion in General Populations: A Scoping Review over the First Year of the Pandemic. PLoS ONE. 2023;18:e0269104. doi: 10.1371/journal.pone.0269104. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
